What Encapsula NanoSciences does

Encapsula NanoSciences LLC is a privately held, Brentwood, Tennessee-based nanotechnology formulator and manufacturer specializing in research-grade liposome products. Founded in 2005 and operating for over 16 years, the company supplies ready-made liposome formulations to more than 1,000 universities, research institutes, government laboratories, biotechnology firms, and pharmaceutical companies across five continents. Its customer base includes Harvard, Stanford, Imperial College London, INSERM, Monash University, MD Anderson, the U.S. National Cancer Institute, Pfizer, Merck, Schering AG, and CNIO. The company positions itself as filling a gap for researchers who lack the equipment or expertise to formulate liposomes in-house.

The company's core technology is lipid-based liposome formulation and manufacturing, executed under sterile conditions with documented quality control. Its proprietary branded catalog spans macrophage-depletion reagents (Clodrosome® and Encapsome® controls), liposomal doxorubicin for cancer research (Doxosome™ and Immunodox®), surface-reactive liposomes for antibody and protein conjugation (Immunosome®, including DBCO/Azide click-chemistry variants), DNA/RNA delivery vehicles (Genesome®), fluorescent liposomes for tracking (Fluoroliposome®, Immunofluor™), lyophilized ATP liposomes (ATPsome®), plain liposomes as artificial cell models (Cellsome®), freeze-dried proliposome kits (Lyophosome™), loadable liposomes (Loadosome), magnetic liposomes (Magnetosome™), and cosmetic proliposomes (Dermasome™). The company holds 11 registered trademarks covering these product lines. Beyond catalog sales, Encapsula offers contract R&D services covering preformulation, encapsulation efficiency optimization, stability studies, scale-up, and patent due diligence for liposome-related IP.

Encapsula operates a sales-led, direct distribution model. Products are sold per unit (vial or mL) at prices ranging from $850 to $1,400+ depending on composition, with volume pricing available and lyophilized formats shipped on dry ice at -78.5°C. The company maintains three regional toll-free support lines (North America, Europe, Asia/Africa/Australia/NZ) and partners with local distributors in Japan, Korea, Taiwan, and China to navigate customs regulations on perishable formulations. Marketing is digital-first, centered on the encapsula.com catalog and educational content on liposomes.org and SlideShare. Revenue is not disclosed, but with a 1–10 person team and a unit-priced specialty catalog, the business operates as a small, technically specialized niche manufacturer rather than a scaled life-sciences platform.

Name

Encapsula NanoSciences

Legal name

Encapsula NanoSciences LLC

Website

https://encapsula.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Encapsula NanoSciences is a Brentwood, Tennessee-based specialty manufacturer that formulates and supplies research-grade liposome products to over 1,000 universities, government laboratories, biotech firms, and pharmaceutical companies worldwide, while also offering contract R&D and liposome patent due diligence services.

Ownership category

akta.pro rank

Product category

Liposome Research Reagents

NAICS

Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Chemicals & Allied Products (2800), Miscellaneous Chemical Products (2890)

akta.pro primary industry

Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)

akta.pro secondary industries

Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL), Solid-State Chemistry & Preformulation (Polymorph/Crystallization) (HLAGAHAI)

Keywords

• Liposome formulation
• Drug delivery research
• Macrophage depletion reagents
• Contract research services
• Fluorescent liposome tracking

Headquarters

HQ city

Brentwood

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Liposome Product Sales: Sale of standardized and custom liposome formulations to research institutions including plain liposomes, drug-loaded liposomes, fluorescent liposomes, and surface-reactive liposomes for conjugation research
2. Contract Research Services: Custom R&D services for government, pharmaceutical, biotechnology, medical device, food and nutraceutical sectors including preformulation studies, serum stability studies, optimization of encapsulation efficiency, physical and chemical stability studies, and scale-up
3. Patent Due Diligence Services: Expert evaluation of patent claims and data for liposome-related technologies to assist companies in licensing or purchasing decisions, including reproducibility assessment and product characterization

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Encapsula NanoSciences is a nanotechnology research and development company that formulates and manufactures specialized liposome-based products for research applications. The company sells standardized and custom liposome formulations (including clodronate liposomes, doxorubicin liposomes, surface-reactive liposomes, DNA/RNA liposomes, fluorescent liposomes, and freeze-dried proliposome kits) to universities, research institutes, government laboratories, and biotechnology and pharmaceutical companies. It also provides contract research services, custom formulation development, and patent due diligence for liposome-related technologies.

Product overview

Encapsula NanoSciences is a nanotechnology research and development company that serves over a thousand universities, research institutes, government laboratories, and biotechnology and pharmaceutical companies across five continents. The company operates as a formulator and manufacturer of liposome-based products, with its core portfolio centered on specialized liposome formulations including Clodrosome® (clodronate liposomes for macrophage depletion), Doxosome™ and Immunodox® (doxorubicin liposomes for drug delivery), Immunosome® (surface-reactive liposomes for antibody conjugation), Genesome® (DNA/RNA liposomes), Fluoroliposome® (fluorescent liposomes for tracking), ATPsome® (ATP liposomes), Cellsome® (plain liposomes as artificial cell models), and Lyophosome™ (freeze-dried proliposome kits). Additional products include Loadosome (loadable liposomes), Magnetosome (magnetic liposomes), and Dermasome (cosmetic proliposomes). The company also offers contract research and development services including formulation development, patent due diligence, and scale-up services.

Differentiator

Problem solved

Functional benefit

Brands

• Clodrosome®: Clodronate liposomes for macrophage depletion
• Doxosome™
• Immunodox®
• Immunosome®
• Genesome®
• Fluoroliposome®
• ATPsome®
• Cellsome®
• Lyophosome™
• Loadosome™
• Magnetosome™
• DermaSOME™
• Encapsome®

Products and services

• Clodrosome®
• Doxosome™
• Immunodox®
• Immunosome®
• Genesome®
• Fluoroliposome®
• ATPsome®
• Cellsome®
• Lyophosome™
• Loadosome
• Magnetosome
• Dermasome
• Encapsome®
• Immunofluor™
• Contract R&D and Patent Due Diligence Services

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

One partnership is on record.

• Regional Distributors (Japan, Korea, Taiwan, China)minorChannel Partner/ Reseller/ DistributorEncapsula partners with regional distributors in markets with complex customs regulations. Distributors facilitate customs clearance for perishable liposome formulations. The company explicitly recommends ordering through distributors for clients in Japan, Korea, Taiwan, and China due to tough customs clearance regulations.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Lipoid: Lipoid is a leading global manufacturer of phospholipids and liposome delivery systems for pharmaceutical, cosmetic and nutraceutical applications. It directly competes with Encapsula in liposome formulation manufacturing and shares a comparable customer base in drug delivery R&D.
• Avanti Polar Lipids: Avanti Polar Lipids supplies high-purity lipids and liposomal reagents used by academic and industrial research laboratories worldwide. It competes head-to-head with Encapsula's Cellsome®, Fluoroliposome® and Lyophosome™ catalog products for research customers.
• FormuMax Scientific: FormuMax Scientific develops and supplies liposome and lipid nanoparticle products for research applications, including preformed and lyophilized formulations. Its catalog directly overlaps with Encapsula's standardized research reagent lines.
• NOF Corporation: NOF manufactures specialty phospholipids and liposome formulations including drug-delivery-grade products. It serves pharmaceutical and research customers similar to Encapsula's biotech/pharma and academic segments, particularly across APAC.

Emerging players

• BOC Sciences: BOC Sciences offers custom liposome preparation services and research-grade liposomal products to academic and industry customers. It competes with Encapsula on custom formulation projects and standardized reagents at typically lower price points.
• Liposoma (Lipoid subsidiary): Liposoma is a CDMO focused exclusively on liposomal drug development and manufacturing for pharmaceutical clients. It is a relevant peer for the contract R&D and scale-up services Encapsula provides to pharma and biotech customers.
• Creative Biolabs: Creative Biolabs offers contract liposome formulation development and drug-delivery services alongside its broader antibody and bio-conjugation business. Its service offering overlaps directly with Encapsula's contract R&D line.
• Cayman Chemical: Cayman Chemical supplies a broad catalog of biochemical research tools, including lipids and liposomal reagents, to academic and pharma researchers. It competes with Encapsula for the same institutional customers across immunology, cancer and drug-delivery research.

Broad incumbents

• Evonik: Evonik operates a specialty lipids and CDMO business that supplies phospholipids and liposome excipients to pharma and nutraceutical customers. Its lipid systems portfolio overlaps with Encapsula's larger-volume nutraceutical and pharmaceutical formulation work.
• Merck KGaA (Sigma-Aldrich): Sigma-Aldrich/Merck distributes a wide portfolio of lipids, reagents and liposomal products to research customers globally. It competes with Encapsula at the catalog-product level but as part of a much broader life-science tools portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/liposomes

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Encapsula NanoSciences